SIRT6 in Vascular Diseases, from Bench to Bedside

Area of Science:

• Gerontology
• Molecular Biology
• Cardiovascular Medicine

Background:

• Aging is a primary risk factor for cardiovascular diseases and angiogenic dysfunction.
• Sirtuins, particularly SIRT6, are key regulators of aging and cardiovascular health.
• SIRT6 plays a critical role in lifespan extension and vascular protection.

Purpose of the Study:

• To review the role of sirtuins in cardiovascular diseases.
• To highlight recent advances in understanding SIRT6's function in vascular biology and aging.
• To discuss the therapeutic potential of SIRT6 activators for age-related vascular disorders.

Main Methods:

• Literature review of experimental analyses in rodents and non-human primates.
• Summary of mechanistic studies on SIRT6's role in vascular diseases.
• Analysis of recent findings on SIRT6 activators like MDL-800/MDL-811.

Main Results:

• SIRT6 exhibits pleiotropic protective actions in angiogenesis and cardiovascular diseases.
• SIRT6 regulates vascular diseases via epigenetic mechanisms in multiple cell types.
• SIRT6 activators demonstrate therapeutic value in preclinical models of vascular disorders.

Conclusions:

• SIRT6 is a critical mediator of vascular health and longevity.
• Targeting SIRT6 offers a promising therapeutic strategy for age-related cardiovascular and cerebrovascular diseases.
• Further research into SIRT6 pathways can unlock new treatments for vascular aging.